Leadership

Novo Nordisk drops the Nordisk

The Danish drugmaker will go by Novo day to day, with a redrawn Apis bull, a new typeface, and a promise that lasting health starts now.

Emma RossiMedia ReporterSep 14, 20264 min read
Novo Nordisk drops the Nordisk
Leadership
Photo: News Øresund - Johan Wessman / Openverse (CC BY 3.0)

A century-old Danish company just made itself shorter. Novo Nordisk announced on Monday that it will use "Novo" as its everyday name, unveiling a full rebrand and a cultural reset that the company frames as the opening of a new chapter. Novo Nordisk A/S remains the legal entity, but the brand people see, hear, and search for is now one word.

The new platform lands on the line "Lasting Health Starts Now," built on the argument that health is a daily accumulation rather than a distant milestone. The Apis bull that has anchored the identity since the 1920s has been redrawn for a flatter, more flexible expression, and the palette leads with a more vivid "Lasting Blue" accented by "Now Turquoise." There is a proprietary typeface, also called Novo, to hold it all together across packaging, clinical materials, and consumer channels.

The timing is not incidental. Chief executive Mike Doustdar took over a business that had lost ground in the obesity market to Eli Lilly and patience with investors who want a clearer path to the next blockbuster. Alongside the identity work, the company published a set of operating principles it calls The Novo Way, promising focus and speed through sharper priorities and simplified workflows. A rebrand rarely fixes a pipeline, but it is a legible signal that the leadership intends to behave differently.

There is also a plain naming logic at work. In markets where Ozempic and Wegovy are household words while the parent company is not, a two-word Danish corporate name is friction. "Novo" is easier to say, easier to type, and easier to own in an environment where consumers ask an assistant about weight-loss drugs before they ever visit a corporate site.

The risk is the one every heritage rebrand carries: shortening a name can read as modernization or as distancing, and pharmaceutical trust is built on the parts of a brand that feel unchanged. Novo has kept the bull and kept the blue, which suggests the company knows exactly which equity it cannot afford to spend. The strategy detail arrives at its Capital Markets Day, and that is where the rebrand will either look like a prelude or like a paint job.

Emma Rossi

Media Reporter, BRNDWIRE. Covering leadership for strategists and marketers worldwide.

More stories

The brand briefing in your inbox

Get the most important brand stories, every morning. No spam, no fluff.

By subscribing, you agree to our privacy policy.